吸入沙美特罗-替卡松治疗慢性阻塞性肺疾病的临床观察  

Clinical observation of inhaling salmeterol-fluticasone in patients with COPD

作　　者：杨艳娟[1] 崔丽萍[1] 郑西卫[1] 陈芳[1] 张鹏[1] 

机构地区：[1]宁夏医科大学附属医院,宁夏银川750004

出　　处：《宁夏医学杂志》2009年第12期1101-1103,共3页Ningxia Medical Journal

摘　　要：目的探讨吸入沙美特罗-替卡松粉治疗慢性阻塞性肺疾病(COPD)的疗效。方法对45例COPD患者在基础治疗的同时吸入沙美特罗-替卡松粉3个月,于治疗前后测定肺功能。45例COPD作为对照组仅仅给予基础治疗,观察两组患者肺功能和临床症状的改善情况。结果吸入沙美特罗-替卡松粉后患者FEV1%、FEV1、PEF、FEV1/FVC、V50、V25、Raw、sGaw较对照组明显改善。结论COPD患者吸入沙美特罗-替卡松粉可改善肺功能和临床症状。Objective To evaluate the clinical effect of inhaling salmeterol-fluticasone on patients with COPD.Methods Salmeterol-fluticasone was inhaled in 45 patients for two times per day in 3 months,then lung function test was measured after and before inhaling salmeterol-fluticasone.Another 45 patients with COPD who took basic treatment as control group were also examined by lung function.Results The FEV1%,FEV1,PEF,FEV1/FVC,V50,V25,Raw and sGaw were markedly improved in COPD patients who were inhaled salmeterol-fluticasone than those in control group.Conclusion The lung function and clinical symptoms of COPD can be evidently improved by inhaling salmeterol-fluticasone.

关 键 词：慢性阻塞性肺疾病 肺功能 沙美特罗-替卡松粉 

分 类 号：R563.9[医药卫生—呼吸系统]